HomeComparePREUF vs JNJ

PREUF vs JNJ: Dividend Comparison 2026

PREUF yields 10.21% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PREUF wins by $2.8K in total portfolio value
10 years
PREUF
PREUF
● Live price
10.21%
Share price
$0.14
Annual div
$0.01
5Y div CAGR
-36%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$13.64
Full PREUF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PREUF vs JNJ

📍 PREUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPREUFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PREUF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PREUF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PREUF
Annual income on $10K today (after 15% tax)
$867.76/yr
After 10yr DRIP, annual income (after tax)
$11.59/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $692.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PREUF + JNJ for your $10,000?

PREUF: 50%JNJ: 50%
100% JNJ50/50100% PREUF
Portfolio after 10yr
$21.4K
Annual income
$420.71/yr
Blended yield
1.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PREUF
No analyst data
Altman Z
0.5
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PREUF buys
0
JNJ buys
0
No recent congressional trades found for PREUF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPREUFJNJ
Forward yield10.21%3.36%
Annual dividend / share$0.01$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-36%5.8%
Portfolio after 10y$22.8K$20.0K
Annual income after 10y$13.64$827.78
Total dividends collected$1.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PREUF vs JNJ ($10,000, DRIP)

YearPREUF PortfolioPREUF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,353$653.37$10,676$355.77+$677.00PREUF
2$12,592$443.69$11,407$389.39+$1.2KPREUF
3$13,768$294.33$12,198$426.53+$1.6KPREUF
4$14,924$192.49$13,056$467.62+$1.9KPREUF
5$16,093$124.80$13,987$513.12+$2.1KPREUF
6$17,300$80.50$14,998$563.56+$2.3KPREUF
7$18,563$51.76$16,098$619.52+$2.5KPREUF
8$19,896$33.22$17,295$681.69+$2.6KPREUF
9$21,310$21.30$18,599$750.82+$2.7KPREUF
10$22,815$13.64$20,022$827.78+$2.8KPREUF

PREUF vs JNJ: Complete Analysis 2026

PREUFStock

Prosperity REIT [SEHK: 808] is a Hong Kong collective investment scheme authorized under section 104 of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). Prosperity REIT owns a diverse portfolio of seven high-quality properties in the decentralized business districts of Hong Kong, comprising all, or a portion of, three Grade A office buildings, one commercial building, two industrial/office buildings and one industrial building, with a total gross rentable area of about 1.28 million sq. ft.

Full PREUF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PREUF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PREUF vs SCHDPREUF vs JEPIPREUF vs OPREUF vs KOPREUF vs MAINPREUF vs ABBVPREUF vs MRKPREUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.